|

Etoposide injection Clinical Trials

3 actively recruiting trials

▼ -1 trial since June 2026

Also known as: VP-16213

Pipeline

Phase 2: 2Phase 3: 1

Top Sponsors

  • Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.1
  • Shanghai Hengrui Pharmaceutical Co., Ltd.1
  • BeBetter Med Inc1

Indications

  • Cancer3
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma1
  • Malignant Solid Tumors1
  • Small Cell Lung Cancer1
  • Lung Cancer1

Other3 trials

A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors
Phase 2
SKB500 Combinations in Patients With Small Cell Lung Cancer
Phase 2
Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.